Status
Terminated
Drug Enforcement D-747-2014
Failed Stability Specifications: this product is below specification for preservative content.
Classification
Class III
Report Date
January 29, 2014
Termination Date
August 27, 2014
Product Information
- Product description
- Fluconazole Oral Suspension, 10 mg/mL, 35 ml bottle, RX only, Mfd by Cipla, Ltd., Goa, India, Dist by Teva Pharmaceuticals USA, Inc., Sellersville, PA. NDC: 0093-5414-95.
- Product quantity
- 234,242 bottles
- Reason for recall
- Failed Stability Specifications: this product is below specification for preservative content.
- Recall initiation reason
- —
- Initial firm notification
- Letter
- Distribution pattern
- Nationwide
Location & Firm
- Recalling firm
- Teva Pharmaceuticals USA, Inc.
- Address
-
650 Cathill Rd
United States - Voluntary / Mandated
- Voluntary: Firm initiated
- Status date
- —
Codes & Dates
- Recall number
- D-747-2014
- Event ID
- 66899
- Recall initiation date
- November 14, 2013
- Center classification date
- January 17, 2014
- Code info
- Lot: (Exp); V10316 (11/13), V10317 (11/13), V10320 (11/13), V10321 (11/13), V20086 (2/14), V20087 (2/14), V20089 (2/14), V20093 (2/14), V20094 (2/14), V20086 (2/14), V20118 (3/14), V20119 (3/14), V20147 (3/14), V20148 (3/14), V20152 (4/14), V20154 (4/14), V20155 (4/14), V20180 (4/14), V20181 (4/14), V20182 (4/14), V20203 (5/14), V20204 (5/14), V20233 (5/14), V20234 (5/14), V20273 (6/14), V20274 (6/14), V20275 (6/14), V20293 (8/14), V20294 (8/14), V20321 (9/14), V20322 (9/14), V20323 (9/14), V20324 (9/14), V20325 (9/14), V20326 (9/14), V20327 (9/14), V20369 (10/14), V20370 (10/14), V20410 (11/14), V20411 (11/14), V20412 (11/14), V30009 (12/14), V30010 (12/14), V30011 (12/14), V30056 (01/15), V30120 (2/15), V30122 (2/15), V30123 (2/15), V30163 (3/15), V30164 (3/15), V30165 (3/15), V30190 (3/15), V30249 (5/15), V30250 (5/15).
- More code info
- —